Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 636

1.

Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.

Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiébaut R, Tanser F, Bärnighausen T, Orne-Gliemann J, Pillay D, Dabis F; ANRS 12249 TasP Study Group.

J Int AIDS Soc. 2019 Oct;22(10):e25402. doi: 10.1002/jia2.25402.

2.

Nosocomial transmission of influenza: A retrospective cross-sectional study using next generation sequencing at a hospital in England (2012-2014).

Blackburn RM, Frampton D, Smith CM, Fragaszy EB, Watson SJ, Ferns RB, Binter Š, Coen PG, Grant P, Shallcross LJ, Kozlakidis Z, Pillay D, Kellam P, Hué S, Nastouli E, Hayward AC; ICONIC group.

Influenza Other Respir Viruses. 2019 Nov;13(6):556-563. doi: 10.1111/irv.12679. Epub 2019 Sep 19.

3.

Findings from home-based HIV testing and facilitated linkage after scale-up of test and treat in rural South Africa: young people still missing.

Baisley KJ, Seeley J, Siedner MJ, Koole K, Matthews P, Tanser F, Bärnighausen T, Smit T, Gareta D, Dlamini S, Herbst K, Hm Y, Cc I, Hy K, D P, M S.

HIV Med. 2019 Nov;20(10):704-708. doi: 10.1111/hiv.12787. Epub 2019 Aug 27.

PMID:
31454139
4.

Comparing the Montreal Cognitive Assessment and Rowland Universal Dementia Assessment Scale in a multicultural rehabilitation setting.

Emerson A, Muruganantham P, Park MY, Pillay D, Vasan N, Park SJ, Van KL, Pampapathi P, Seow CS, Yau SM.

Intern Med J. 2019 Aug;49(8):1035-1040. doi: 10.1111/imj.14392.

PMID:
31387144
5.

Ultra-rapid, sensitive and specific digital diagnosis of HIV with a dual-channel SAW biosensor in a pilot clinical study.

Gray ER, Turbé V, Lawson VE, Page RH, Cook ZC, Ferns RB, Nastouli E, Pillay D, Yatsuda H, Athey D, McKendry RA.

NPJ Digit Med. 2018 Aug 17;1:35. doi: 10.1038/s41746-018-0041-5. eCollection 2018.

6.

Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis.

Chimukangara B, Lessells RJ, Rhee SY, Giandhari J, Kharsany ABM, Naidoo K, Lewis L, Cawood C, Khanyile D, Ayalew KA, Diallo K, Samuel R, Hunt G, Vandormael A, Stray-Pedersen B, Gordon M, Makadzange T, Kiepiela P, Ramjee G, Ledwaba J, Kalimashe M, Morris L, Parikh UM, Mellors JW, Shafer RW, Katzenstein D, Moodley P, Gupta RK, Pillay D, Abdool Karim SS, de Oliveira T.

EClinicalMedicine. 2019 Mar 18;9:26-34. doi: 10.1016/j.eclinm.2019.03.006. eCollection 2019 Mar.

7.

Clients' experiences utilizing a safer conception service for HIV affected individuals: implications for differentiated care service delivery models.

Schwartz S, Davies N, Naidoo N, Pillay D, Makhoba N, Mullick S.

Reprod Health. 2019 May 29;16(Suppl 1):65. doi: 10.1186/s12978-019-0718-5.

8.

Eutrophication overrides warming as a stressor for a temperate African seagrass (Zostera capensis).

Mvungi EF, Pillay D.

PLoS One. 2019 Apr 11;14(4):e0215129. doi: 10.1371/journal.pone.0215129. eCollection 2019.

9.

PANGEA-HIV 2: Phylogenetics And Networks for Generalised Epidemics in Africa.

Abeler-Dörner L, Grabowski MK, Rambaut A, Pillay D, Fraser C; PANGEA consortium.

Curr Opin HIV AIDS. 2019 May;14(3):173-180. doi: 10.1097/COH.0000000000000542.

10.

Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis.

Ratmann O, Grabowski MK, Hall M, Golubchik T, Wymant C, Abeler-Dörner L, Bonsall D, Hoppe A, Brown AL, de Oliveira T, Gall A, Kellam P, Pillay D, Kagaayi J, Kigozi G, Quinn TC, Wawer MJ, Laeyendecker O, Serwadda D, Gray RH, Fraser C; PANGEA Consortium and Rakai Health Sciences Program.

Nat Commun. 2019 Mar 29;10(1):1411. doi: 10.1038/s41467-019-09139-4.

11.

Validation and effect on diabetes control of glycated haemoglobin (HbA1c) point-of-care testing.

Pillay S, Aldous CM, Singh D, Pillay D.

S Afr Med J. 2019 Jan 31;109(2):112-115. doi: 10.7196/SAMJ.2019.v109i2.13447.

12.

Taking connected mobile-health diagnostics of infectious diseases to the field.

Wood CS, Thomas MR, Budd J, Mashamba-Thompson TP, Herbst K, Pillay D, Peeling RW, Johnson AM, McKendry RA, Stevens MM.

Nature. 2019 Feb;566(7745):467-474. doi: 10.1038/s41586-019-0956-2. Epub 2019 Feb 27. Review.

13.

Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population.

Tomita A, Vandormael A, Bärnighausen T, Phillips A, Pillay D, De Oliveira T, Tanser F.

AIDS. 2019 Mar 1;33(3):559-569. doi: 10.1097/QAD.0000000000002100.

PMID:
30702520
14.

Prospective observational cohort study on grading the severity of postoperative complications in global surgery research.

International Surgical Outcomes Study (ISOS) group.

Br J Surg. 2019 Jan;106(2):e73-e80. doi: 10.1002/bjs.11025.

PMID:
30620066
15.

No effect of test and treat on sexual behaviours at population level in rural South Africa.

Rolland M, McGrath N, Tiendrebeogo T, Larmarange J, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP study group.

AIDS. 2019 Mar 15;33(4):709-722. doi: 10.1097/QAD.0000000000002104.

PMID:
30608273
16.

High HIV incidence and low uptake of HIV prevention services: The context of risk for young male adults prior to DREAMS in rural KwaZulu-Natal, South Africa.

Baisley K, Chimbindi N, Mthiyane N, Floyd S, McGrath N, Pillay D, Seeley J, Zuma T, Dreyer J, Gareta D, Smit T, Mutevedzi T, Fenty J, Herbst K, Birdthistle I, Shahmanesh M.

PLoS One. 2018 Dec 26;13(12):e0208689. doi: 10.1371/journal.pone.0208689. eCollection 2018.

17.

Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial).

Gosset A, Protopopescu C, Larmarange J, Orne-Gliemann J, McGrath N, Pillay D, Dabis F, Iwuji C, Boyer S.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):375-385. doi: 10.1097/QAI.0000000000001938.

18.

Tracking external introductions of HIV using phylodynamics reveals a major source of infections in rural KwaZulu-Natal, South Africa.

Rasmussen DA, Wilkinson E, Vandormael A, Tanser F, Pillay D, Stadler T, de Oliveira T.

Virus Evol. 2018 Dec 11;4(2):vey037. doi: 10.1093/ve/vey037. eCollection 2018 Jul.

19.

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction.

Mbisa JL, Kirwan P, Tostevin A, Ledesma J, Bibby DF, Brown A, Myers R, Hassan AS, Murphy G, Asboe D, Pozniak A, Kirk S, Gill ON, Sabin C, Delpech V, Dunn DT; UK HIV Drug Resistance Database .

Clin Infect Dis. 2019 Sep 13;69(7):1136-1143. doi: 10.1093/cid/ciy1048.

PMID:
30534981
20.

Linkage to primary care after home-based blood pressure screening in rural KwaZulu-Natal, South Africa: a population-based cohort study.

Siedner MJ, Baisley K, Orne-Gliemann J, Pillay D, Koole O, Wong EB, Matthews P, Tanser F, Herbst K, Barnighausen T, Bachmann M.

BMJ Open. 2018 Dec 6;8(12):e023369. doi: 10.1136/bmjopen-2018-023369.

21.

Reply to Ambrosioni et al.

Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD.

Clin Infect Dis. 2019 May 17;68(11):1977-1978. doi: 10.1093/cid/ciy1022. No abstract available.

PMID:
30520997
22.

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study.

Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A.

Lancet HIV. 2019 Feb;6(2):e116-e127. doi: 10.1016/S2352-3018(18)30317-5. Epub 2018 Nov 29.

23.

Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis.

Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD; WHO–UNAIDS Network for HIV Isolation Characterisation.

Lancet Infect Dis. 2019 Feb;19(2):143-155. doi: 10.1016/S1473-3099(18)30647-9. Epub 2018 Nov 30.

PMID:
30509777
24.

Sources of social support and sexual behaviour advice for young adults in rural South Africa.

Harling G, Gumede D, Shahmanesh M, Pillay D, Bärnighausen TW, Tanser F.

BMJ Glob Health. 2018 Nov 22;3(6):e000955. doi: 10.1136/bmjgh-2018-000955. eCollection 2018.

25.

Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa.

Chimukangara B, Kharsany ABM, Lessells RJ, Naidoo K, Rhee SY, Manasa J, Gräf T, Lewis L, Cawood C, Khanyile D, Diallo K, Ayalew KA, Shafer RW, Hunt G, Pillay D, Abdool SK, de Oliveira T.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):129-138. doi: 10.1089/AID.2018.0202. Epub 2019 Jan 7.

PMID:
30430843
26.

"If you are here at the clinic, you do not know how many people need help in the community": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat.

Perriat D, Plazy M, Gumede D, Boyer S, Pillay D, Dabis F, Seeley J, Orne-Gliemann J; ANRS 12249 TasP Study Group.

PLoS One. 2018 Nov 9;13(11):e0202473. doi: 10.1371/journal.pone.0202473. eCollection 2018.

27.

Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.

Derache A, Iwuji CC, Danaviah S, Giandhari J, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Pillay D, Gupta RK.

J Antimicrob Chemother. 2019 Feb 1;74(2):473-479. doi: 10.1093/jac/dky428.

28.

Persistently high incidence of HIV and poor service uptake in adolescent girls and young women in rural KwaZulu-Natal, South Africa prior to DREAMS.

Chimbindi N, Mthiyane N, Birdthistle I, Floyd S, McGrath N, Pillay D, Seeley J, Zuma T, Dreyer J, Gareta D, Mutevedzi T, Fenty J, Herbst K, Smit T, Baisley K, Shahmanesh M.

PLoS One. 2018 Oct 16;13(10):e0203193. doi: 10.1371/journal.pone.0203193. eCollection 2018.

29.

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.

Derache A, Iwuji CC, Baisley K, Danaviah S, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Porter K, Pillay D.

Clin Infect Dis. 2019 Jul 2;69(2):207-214. doi: 10.1093/cid/ciy881.

30.

Improving the Validity of Mathematical Models for HIV Elimination by Incorporating Empirical Estimates of Progression Through the HIV Treatment Cascade.

Chang AY, Haber N, Bärnighausen T, Herbst K, Gareta D, Pillay D, Salomon JA.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):596-604. doi: 10.1097/QAI.0000000000001852.

PMID:
30272631
31.

Ethical considerations in global HIV phylogenetic research.

Coltart CEM, Hoppe A, Parker M, Dawson L, Amon JJ, Simwinga M, Geller G, Henderson G, Laeyendecker O, Tucker JD, Eba P, Novitsky V, Vandamme AM, Seeley J, Dallabetta G, Harling G, Grabowski MK, Godfrey-Faussett P, Fraser C, Cohen MS, Pillay D; Ethics in HIV Phylogenetics Working Group.

Lancet HIV. 2018 Nov;5(11):e656-e666. doi: 10.1016/S2352-3018(18)30134-6. Epub 2018 Aug 30. Review.

PMID:
30174214
32.

Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children.

Rocca S, Zangari P, Cotugno N, De Rossi A, Ferns B, Petricone D, Rinaldi S, Giaquinto C, Bernardi S, Rojo P, Rossi P, Pahwa S, Nastouli E, Palma P; EPIICAL Consortium .

J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):433-438. doi: 10.1093/jpids/piy080.

33.
34.

The MONARCH intervention to enhance the quality of antenatal and postnatal primary health services in rural South Africa: protocol for a stepped-wedge cluster-randomised controlled trial.

Chetty T, Yapa HMN, Herbst C, Geldsetzer P, Naidu KK, De Neve JW, Herbst K, Matthews P, Pillay D, Wyke S, Bärnighausen T; MONARCH study team.

BMC Health Serv Res. 2018 Aug 8;18(1):625. doi: 10.1186/s12913-018-3404-3.

35.

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD.

Clin Infect Dis. 2019 Jan 7;68(2):177-187. doi: 10.1093/cid/ciy463.

36.

The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).

Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiébaut R, Tanser F, Bärnighausen T, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP Study Group.

J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25128. doi: 10.1002/jia2.25128.

37.

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV.

Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Phillips AN, Sabin CA, Post FA; UK CHIC Study.

J Infect Dis. 2018 Oct 20;218(11):1767-1772. doi: 10.1093/infdis/jiy397.

38.

Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa.

Kluberg SA, Fox MP, LaValley M, Pillay D, Bärnighausen T, Bor J.

Trop Med Int Health. 2018 Sep;23(9):968-979. doi: 10.1111/tmi.13122. Epub 2018 Jul 26.

39.

Skydiving: The audiological perspective.

Pillay D, Dada S.

S Afr J Commun Disord. 2018 May 28;65(1):e1-e4. doi: 10.4102/sajcd.v65i1.553.

40.

A pilot study: Considering spirituality in an inclusive model of practice in clinical audiology.

Pillay D, Moonsamy S.

S Afr J Commun Disord. 2018 Jun 21;65(1):e1-e6. doi: 10.4102/sajcd.v65i1.552.

41.

The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa.

Hu J, Geldsetzer P, Steele SJ, Matthews P, Ortblad K, Solomon T, Shroufi A, van Cutsem G, Tanser F, Wyke S, Vollmer S, Pillay D, McConnell M, Bärnighausen T.

AIDS. 2018 Sep 10;32(14):2067-2073. doi: 10.1097/QAD.0000000000001924.

42.

A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study.

Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, Sabin CA; UK CHIC Study Steering Committee.

Lancet HIV. 2018 Jun;5(6):e301-e308. doi: 10.1016/S2352-3018(18)30048-1.

43.

Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.

Iwuji C, McGrath N, Calmy A, Dabis F, Pillay D, Newell ML, Baisley K, Porter K.

J Int AIDS Soc. 2018 Jun;21(6):e25112. doi: 10.1002/jia2.25112.

44.

HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa.

Ekoru K, Young EH, Dillon DG, Gurdasani D, Stehouwer N, Faurholt-Jepsen D, Levitt NS, Crowther NJ, Nyirenda M, Njelekela MA, Ramaiya K, Nyan O, Adewole OO, Anastos K, Compostella C, Dave JA, Fourie CM, Friis H, Kruger IM, Longenecker CT, Maher DP, Mutimura E, Ndhlovu CE, Praygod G, Pefura Yone EW, Pujades-Rodriguez M, Range N, Sani MU, Sanusi M, Schutte AE, Sliwa K, Tien PC, Vorster EH, Walsh C, Gareta D, Mashili F, Sobngwi E, Adebamowo C, Kamali A, Seeley J, Smeeth L, Pillay D, Motala AA, Kaleebu P, Sandhu MS.

Glob Health Epidemiol Genom. 2018;3. pii: e7. doi: 10.1017/gheg.2018.7. Epub 2018 May 8.

45.

Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak.

Houlihan CF, Frampton D, Ferns RB, Raffle J, Grant P, Reidy M, Hail L, Thomson K, Mattes F, Kozlakidis Z, Pillay D, Hayward A, Nastouli E.

J Infect Dis. 2018 Sep 22;218(9):1485-1489. doi: 10.1093/infdis/jiy335. Erratum in: J Infect Dis. 2019 Apr 8;219(8):1347.

46.

HIV Treatment Substantially Decreases Hospitalization Rates: Evidence From Rural South Africa.

Hontelez JAC, Bor J, Tanser FC, Pillay D, Moshabela M, Bärnighausen T.

Health Aff (Millwood). 2018 Jun;37(6):997-1004. doi: 10.1377/hlthaff.2017.0820.

47.

List randomization for eliciting HIV status and sexual behaviors in rural KwaZulu-Natal, South Africa: a randomized experiment using known true values for validation.

Haber N, Harling G, Cohen J, Mutevedzi T, Tanser F, Gareta D, Herbst K, Pillay D, Bärnighausen T, Fink G.

BMC Med Res Methodol. 2018 May 25;18(1):46. doi: 10.1186/s12874-018-0507-9.

48.

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.

Stirrup OT, Dunn DT, Tostevin A, Sabin CA, Pozniak A, Asboe D, Cox A, Orkin C, Martin F, Cane P; UK HIV Drug Resistance Database; UK Collaborative HIV Cohort.

AIDS Res Ther. 2018 Apr 16;15(1):11. doi: 10.1186/s12981-018-0198-7.

49.

Preservation of residual hearing after cochlear implant surgery: an exploration of residual hearing function in a group of recipients at cochlear implant units.

Gautschi-Mills K, Khoza-Shangase K, Pillay D.

Braz J Otorhinolaryngol. 2019 May - Jun;85(3):310-318. doi: 10.1016/j.bjorl.2018.02.006. Epub 2018 Mar 24.

50.

Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site.

Francis SC, Mthiyane TN, Baisley K, Mchunu SL, Ferguson JB, Smit T, Crucitti T, Gareta D, Dlamini S, Mutevedzi T, Seeley J, Pillay D, McGrath N, Shahmanesh M.

PLoS Med. 2018 Feb 27;15(2):e1002512. doi: 10.1371/journal.pmed.1002512. eCollection 2018 Feb.

Supplemental Content

Loading ...
Support Center